Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01902784 · ClinicalTrials.gov registry record · Phase 1

The Surrogate Project (Surrogate Storytelling)

A Phase 1 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 1
Development phase
115
Enrollment target

NCT01902784 is a Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 115 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01902784, a Phase 1 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 1
Development phase
115 participants
Enrollment target

Study Summary

Research Protocol Abstract: This is a phase II controlled trial (RCT) of a "storytelling" intervention compared to no treatment among surrogates who have participated in a decision to limit life-sustaining treatment in the ICU for an incapacitated loved one. Subjects will be sequentially assigned to "storytelling" (a facilitated elicitation of the experience 2-4 weeks after bereavement) or no treatment with follow up "monitoring of well-being". Subjects will receive print bereavement brochures at 1 week, and undergo telephone symptom assessment at 2-weeks, 3-months, and 6-months after bereavement.

Interventions

  • BEHAVIORAL Storytelling Interview

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2013-06
Est. Completion 2014-11
Phase Phase 1

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01902784

The ClinicalTrials.gov registry entry for NCT01902784 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Storytelling Interview is the first listed.

NCT01902784 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01902784 about?

NCT01902784 is a clinical study titled "The Surrogate Project (Surrogate Storytelling)". Research Protocol Abstract: This is a phase II controlled trial (RCT) of a "storytelling" intervention compared to no treatment among surrogates who have participated in a decision to limit life-sustaining treatment in the ICU for an incapacitated loved one. Subjects will be sequentially assigned t...

What is the current status of trial NCT01902784?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 115 participants. The study started on 2013-06. Estimated completion is 2014-11.

What interventions are being tested in trial NCT01902784?

The interventions under investigation include: Storytelling Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT01902784?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.